Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B
Kavakli, K., Smith, L., Kuliczkowski, K., Korth-Bradley, J., You, C. W., Fuiman, J., Zupančić-Šalek, S., Abdul Karim, F., Rendo, P.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2016)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2016)
Get full text
Journal Article
Clinical experience with moroctocog alfa (AF‐CC) in younger paediatric patients with severe haemophilia A: Two open‐label studies
Rusen, L., Kavakli, K., Korth‐Bradley, J., Huard, F., Rendo, P., Fuiman, J., Baumann, J. A., Smith, L., Alvey, C., Rupon, J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2018)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2018)
Get full text
Journal Article
PB0186 Results from BeneGene-1 Study: Prospective Collection of Bleeding Rate in Hemophilia B Patients Prior to Phase 3 Study (BeneGene-2) of Fidanacogene Elaparvovec
Matino, D., Alzahrani, H., Cuker, A., Astermark, J., Frenzel, L., Katsarou, O., Kavakli, K., Klamroth, R., Shapiro, A., Wang, J., Fuiman, J., McKay, J., Sun, P., Rupon, J.
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Get full text
Journal Article
OC 52.3 Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial
Cuker, A., Alzahrani, H., Astermark, J., Frenzel, L., Katsarou, O., Kavakli, K., Klamroth, R., Matino, D., Shapiro, A., Wang, J., Fuiman, J., McKay, J., Sun, P., Rupon, J.
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Get full text
Journal Article
Treatment satisfaction among patients with psoriasis who were treated with two different dose regimens of etanercept: results from the Pristine study
Lee, WR, Youn, JI, Altmeyer, P, Mallbris, L, Fuiman, J, Pedersen, R, Boggs, R
Published in JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Get full text
Published in JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Conference Proceeding